🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

New therapies for #MCL: an overview including insights on prognostication, current management & novel agents: fal.cn/3swlC #ASCOEdBook #lymsm #ASCO22 ⭕Blaise13💙 Toby Eyre Katharine Lewis Meghan Thompson Chan Cheah

Excited to share this manuscript. Patient characteristics predict Richters Transformation in patients with #CLL treated with ibrutinib. AmericanJournalofHematology Ohio State Hematology Kerry Rogers Seema Ali Bhat onlinelibrary.wiley.com/doi/10.1002/aj…

👉👉👉 Excited to share results of nivolumab + ibrutinib in patients with Richter Transformation | Published today in Blood Advances -24 pts DLBCL RT -Median prior Rx for CLL/RT = 3 -10/24 (42%) had a response (64% BTKi-naive; 23% BTKi-exposed) -Median DOR 15 mos #CLL #lymsm

Catch the latest on sequential strategies and the recent new approval in #CLL❗️ With Drs. Gribben, Allan, Lamanna, and Thompson (Meghan Thompson) Come grab lunch (or watch at home on your device!) 👀 @CLLSociety #ASH23 #MedEd #MedTwitter 🙌

Congratulations to Omar Abdel-Wahab of Abdel-Wahab Lab for receiving the 2023 William Dameshek Prize at #ASH23 to honor his outstanding contributions in #hematology. Learn more about Dr. Abdel-Wahab's work in this article by Memorial Sloan Kettering Cancer Center: buff.ly/3GEYgHq

Find out how to address practical therapy delivery and safety considerations with BTKi therapy while working within the #CLL management team. Developed with @CLLSociety! A live virtual symposium on 1/17 at 12:00 PM EST: bit.ly/RRCLL24T #MedEd Meghan Thompson calliecoombs

Ecstatic to announce our lab’s new paper in Science Magazine in collaboration with Abdel-Wahab Lab and Nurix Therapeutics led by @Skye_Montoya, Jessie Bourcier (Jessie Bourcier), Mark Noviski and Hao Lu. Sylvester Comprehensive Cancer Center Memorial Sloan Kettering Cancer Center #science #biology #cancer science.org/doi/10.1126/sc…

Overcoming resistance to BTK inhibitors remains a critical unmet need for CLL pts. Great collaborative effort to further understand mechanisms of BTKi resistance and proof of concept work showing BTK degraders are a promising therapeutic modality that may overcome resistance

Exciting edition of the MSK Department of Medicine lymphoma #lymsm symposium! Women in Lymphoma - [email protected] Laurie Sehn Gita Thanarajasingam I Buvat Pallawi Torka Teresa Palomero Julie Vose Lia Palomba M Lim S Sarosiek A Noy A Kumar Kate Cwynarski Soni Smith MD Ann LaCasce, MD A Moskowitz Meghan Thompson J Lue C Owens

Next WK in #Chicago, my first annual LIVE #HemOnc Pulse Pod w superb faculty debating “Unanswered Questions” in Heme cancers. Stay tuned & follow #HOPLive24. Joined by Vincent Rajkumar Rafael Fonseca MD 🦔🇺🇸🏜🇲🇽 Sanam Loghavi, MD صنم لغوی 🔬🧬 Saad Z. Usmani MD MBA FACP 🇺🇸🇵🇰 Naveen Pemmaraju, MD Mehdi Hamadani, MD Sangeetha Venugopal MD,MS Meghan Thompson & many more.

From the stage. Unanswered Questions in CLL. Mazyar Shadman, MD MPH presenting with great super brain power in the audience. Alan Skarbnik Aaron Goodman - “Papa Heme” Sanam Loghavi, MD صنم لغوی 🔬🧬 Meghan Thompson Andrew M. Evens, DO, MBA, MSc Naveen Pemmaraju, MD

Great exchange of ideas at #HOPLive24

Consensus Recommendations from the 2024 Lymphoma Research Foundation Workshop on Treatment Selection and Sequencing in CLL or SLL ashpublications.org/bloodadvances/… It was awesome to collaborate with great colleagues and friends on this! Thanks Lymphoma Research Foundation for the support. Deborah Stephens

Looking forward to this program!

Looking forward to discussing updates in CLL at this event!

🎥 Hear from Dr. Krish Patel as he shares what to expect at PeerView’s TownHall symposium on #CLL care during #ASCO25! Join him, Nitin Jain, Meghan Thompson & CLL Society Inc. for this interactive session on 5/31. 📍 Grand Ballroom B, Hyatt Chicago 🔗 bit.ly/CLL-25T